Clinical Trials Logo

Clinical Trial Summary

This is a phase 3, multi-center, prospective, open-label, single-arm, clinical trial to be carried out in subjects with congenital fibrinogen deficiency manifested as afibrinogenemia or severe hypofibrinogenemia. This clinical trial is planned to be performed at study sites in multiple countries. It is planned to include a maximum of 32 adult and pediatric subjects with congenital fibrinogen deficiency in order to provide at least 28 evaluable acute bleeding episodes and/or surgical procedures.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04636268
Study type Interventional
Source Grifols Therapeutics LLC
Contact
Status Withdrawn
Phase Phase 3
Start date December 2023
Completion date March 2025

See also
  Status Clinical Trial Phase
Withdrawn NCT00916656 - Fibrinogen Concentrate (Human) - Efficacy and Safety Study Phase 3
Completed NCT05780125 - Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness Phase 2
Recruiting NCT03884725 - Fibrinogen Concentrate In Children Cardiac Surgery 2 Phase 4
Not yet recruiting NCT06434389 - A Point-of-care Electrochemical-based Device for Rapid Detection of Fibrinogen on Type A Aortic Dissection Surgery
Completed NCT02822599 - Human Fibrinogen Concentrate in Pediatric Cardiac Surgery Phase 4
Recruiting NCT05634005 - Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence N/A
Recruiting NCT05711524 - Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen to Expedite Product Availability in Perioperative Bleeding Phase 4